The IPO Buzz
IPO Calendar
Last Week's IPO Traffic
Pricings
2015 Pricings
Last 100 IPOs
Last 12 Months
IPOs by Managers
By Industry
Secondary Offerings
IPO Pipeline
SCOOP Ratings
IPOs Recently Filed
IPOs by Managers
By Industry
Secondary Offerings
Archives
SCOOP Track Record From 2000 to Present
IPO Traffic by Week
IPO Index
Invuity 
General Information
Business: We are a commercial-stage medical technology company pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during minimally invasive and minimal access surgical procedures. We integrate our Intelligent Photonics technology platform into our single-use and reusable advanced surgical devices to address some of the critical intracavity illumination and visualization challenges facing surgeons today. We utilize our proprietary Intelligent Photonics technology to develop optical waveguides that direct and shape thermally cool, brilliant light into broad, uniform and volumetric illumination of the surgical target. We believe that improving a surgeon’s ability to see critical anatomical structures can lead to better clinical and aesthetic outcomes, improved patient safety and reduced surgical time and healthcare costs. We sold our devices to approximately 350 hospitals in the fourth quarter of 2014, as compared to approximately 150 hospitals in the same quarter of 2013. Based on the number of single-use units we have shipped as of December 31, 2014, we estimate that our devices have been used in over 74,000 surgical procedures.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 116 Founded: 2004
Contact Information
Address: 444 De Haro Street, San Francisco, CA 94107, US
Phone: (415) 655-2100
Web Address: www.invuity.com
View Prospectus: Invuity
Financial Information
Market Cap: $ 152.4 mil
Revenues: $ 15.4 mil (last 12 months)
Net Income: $ -24.98 mil (last 12 months)
IPO Profile
Symbol: IVTY
Shares (millions): 4.0
Price Range: $12.00 - $12.00
Est.$ Volume $ 48.0 mil
Manager / Joint Managers Piper Jaffray/ Leerink Partners/ Stifel
Co Managers William Blair
Expected to Trade 6/15/2015
Status Priced
SCOOP RATING Available only to Subscribers
RATING CHANGE Available only to Subscribers


 
© 2024 IPOSCOOP.com All rights reserved.